Brief report
Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors
Resistencia a ertapenem en 2 instituciones hospitalarias de alto nivel de complejidad: microbiología, epidemiología y factores de riesgo
Natalia Maldonadoa,
, Bibiana Castrob, Indira Berrioc, Miguel Manjarrésd, Carlos Robledoa,e, Jaime Robledoa,e,f
Corresponding author
a Laboratorio Médico de Referencia, Medellín, Colombia
b Dirección de Gestión de Conocimiento, Universidad CES, Medellín, Colombia
c Clínica El Rosario Sede Centro, Medellín, Colombia
d Clínica El Rosario Sede Tesoro, Medellín, Colombia
e Clínica El Rosario, Medellín, Colombia
f Unidad de Bacteriología y Micobacterias, Corporación para Investigaciones Biológicas (CIB), Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana, Medellín, Colombia
Read
2431
Timeswas read the article
537
Total PDF
1894
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 23 | 18 | 41 |
| 2025 11 | 75 | 37 | 112 |
| 2025 10 | 68 | 17 | 85 |
| 2025 9 | 46 | 16 | 62 |
| 2025 8 | 68 | 14 | 82 |
| 2025 7 | 72 | 6 | 78 |
| 2025 6 | 59 | 6 | 65 |
| 2025 5 | 70 | 10 | 80 |
| 2025 4 | 42 | 8 | 50 |
| 2025 3 | 50 | 5 | 55 |
| 2025 2 | 27 | 9 | 36 |
| 2025 1 | 38 | 3 | 41 |
| 2024 12 | 30 | 3 | 33 |
| 2024 11 | 19 | 2 | 21 |
| 2024 10 | 16 | 3 | 19 |
| 2024 9 | 44 | 10 | 54 |
| 2024 8 | 28 | 3 | 31 |
| 2024 7 | 28 | 0 | 28 |
| 2024 6 | 22 | 2 | 24 |
| 2024 5 | 19 | 7 | 26 |
| 2024 4 | 22 | 10 | 32 |
| 2024 3 | 34 | 4 | 38 |
| 2024 2 | 13 | 1 | 14 |
| 2024 1 | 15 | 2 | 17 |
| 2023 12 | 12 | 1 | 13 |
| 2023 11 | 19 | 2 | 21 |
| 2023 10 | 24 | 4 | 28 |
| 2023 9 | 18 | 1 | 19 |
| 2023 8 | 15 | 0 | 15 |
| 2023 7 | 7 | 7 | 14 |
| 2023 6 | 6 | 1 | 7 |
| 2023 5 | 28 | 2 | 30 |
| 2023 4 | 23 | 0 | 23 |
| 2023 3 | 53 | 0 | 53 |
| 2023 2 | 16 | 5 | 21 |
| 2023 1 | 18 | 1 | 19 |
| 2022 12 | 23 | 4 | 27 |
| 2022 11 | 19 | 7 | 26 |
| 2022 10 | 20 | 5 | 25 |
| 2022 9 | 11 | 9 | 20 |
| 2022 8 | 16 | 4 | 20 |
| 2022 7 | 19 | 7 | 26 |
| 2022 6 | 14 | 5 | 19 |
| 2022 5 | 22 | 6 | 28 |
| 2022 4 | 15 | 10 | 25 |
| 2022 3 | 22 | 6 | 28 |
| 2022 2 | 10 | 7 | 17 |
| 2022 1 | 27 | 5 | 32 |
| 2021 12 | 24 | 9 | 33 |
| 2021 11 | 6 | 6 | 12 |
| 2021 10 | 9 | 12 | 21 |
| 2021 9 | 12 | 6 | 18 |
| 2021 8 | 10 | 7 | 17 |
| 2021 7 | 9 | 10 | 19 |
| 2021 6 | 11 | 10 | 21 |
| 2021 5 | 12 | 6 | 18 |
| 2021 4 | 19 | 6 | 25 |
| 2021 3 | 21 | 7 | 28 |
| 2021 2 | 14 | 4 | 18 |
| 2021 1 | 9 | 9 | 18 |
| 2020 12 | 9 | 9 | 18 |
| 2020 11 | 6 | 4 | 10 |
| 2020 10 | 7 | 4 | 11 |
| 2020 9 | 13 | 11 | 24 |
| 2020 8 | 15 | 6 | 21 |
| 2020 7 | 7 | 5 | 12 |
| 2020 6 | 9 | 8 | 17 |
| 2020 5 | 13 | 10 | 23 |
| 2020 4 | 6 | 1 | 7 |
| 2020 3 | 11 | 3 | 14 |
| 2020 2 | 11 | 1 | 12 |
| 2020 1 | 9 | 11 | 20 |
| 2019 12 | 12 | 7 | 19 |
| 2019 11 | 12 | 4 | 16 |
| 2019 10 | 5 | 0 | 5 |
| 2019 9 | 5 | 4 | 9 |
| 2019 8 | 5 | 2 | 7 |
| 2019 7 | 8 | 7 | 15 |
| 2019 6 | 18 | 15 | 33 |
| 2019 5 | 56 | 8 | 64 |
| 2019 4 | 20 | 5 | 25 |
| 2019 3 | 2 | 3 | 5 |
| 2019 2 | 4 | 2 | 6 |
| 2019 1 | 4 | 0 | 4 |
| 2018 12 | 1 | 2 | 3 |
| 2018 11 | 7 | 2 | 9 |
| 2018 10 | 7 | 4 | 11 |
| 2018 9 | 7 | 4 | 11 |
| 2018 8 | 6 | 0 | 6 |
| 2018 7 | 7 | 1 | 8 |
| 2018 6 | 4 | 1 | 5 |
| 2018 5 | 2 | 0 | 2 |
| 2018 4 | 3 | 0 | 3 |
| 2018 1 | 6 | 0 | 6 |
| 2017 12 | 4 | 2 | 6 |
| 2017 11 | 17 | 3 | 20 |
| 2017 10 | 15 | 1 | 16 |
Show all
